Matthew Duffy | executive |
Jonathan Javitt | executive |
Stephen Willard | executive |
Richard Narido | executive |
Edward Woo | analyst |
Good afternoon, everyone, and welcome to the NRx Pharmaceuticals, Inc.
Second Quarter of 2024 Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I will now turn the call over to Matthew Duffy, the company's Chief Business Officer. Please go ahead.